ConocoPhillips (NYSE:COP) said first-quarter profit slipped, but revenue rose, boosted by higher average selling prices for natural gas and increased production at its continuing operations, excluding Libya. ConocoPhillips (NYSE:COP) shares after opening at $75.03 moved to $75.03 on last trade day and at the end of the day closed at $74.31. Company price to sales ratio in past twelve months was calculated as 1.62 and price to cash ratio as 13.99. ConocoPhillips (NYSE:COP) showed a positive weekly performance of 0.39%.
A California federal judge said Wednesday that he wasn’t inclined to invalidate a keyboard patent BlackBerry Ltd. (NASDAQ:BBRY) has accused Ryan Seacrest-backed Typo Products LLC of infringing, tentatively rejecting Typo’s claim that the patent is bogus because Smith Corona patented similar keyboard setups years before BlackBerry. BlackBerry Ltd (NASDAQ:BBRY) shares fell -0.13% in last trading session and ended the day on $7.66. BBRY return on equity ratio is recorded as -8.67% and its return on assets is -6.35%. BlackBerry Ltd (NASDAQ:BBRY) yearly performance is -52.98%.
Endocyte, Inc. (NASDAQ:ECYT) on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Pharmaceuticals industry. The net income has significantly decreased by 241.8% when compared to the same quarter one year ago, falling from -$0.85 million to -$2.90 million. Endocyte, Inc. (NASDAQ:ECYT) shares moved down -1.04% in last trading session and was closed at $18.11, while trading in range of $17.35 – $18.14. Endocyte, Inc. (NASDAQ:ECYT) year to date (YTD) performance is 69.57%.
Avon Products Inc. (NYSE:AVP) would pay the U.S. government $135 million to settle a multiyear bribery probe into its overseas business development practices, under a preliminary agreement the beauty products company disclosed on Thursday. Avon Products, Inc. (NYSE:AVP) weekly performance is 3.45%. On last trading day company shares ended up $15.28. Avon Products, Inc. (NYSE:AVP) distance from 50-day simple moving average (SMA50) is 2.56%. Analysts mean target price for the company is $18.53.
Leave a Reply